ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Fiasp ultra-fast-acting, Injektionslösung - 10 ml
66202001 Novo Nordisk Pharma AG
Fiasp ultra-fast-acting, Injektionslösung07.06.2017
  07.06.2017
Insulin Aspart (A10AB05) 
WHO-DDD 
07.06.10.10 ml
07.06.10. 
B  
Yes 
IPCI
20.96No
    
10 %39.20
7680662020016Biotechnologika
7136642 
Composition
insulinum aspartum 600 nmol corresp. insulinum aspartum 100 U., glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Insulin Aspart600
Nmol 
BAG: Active AgentDose
Insulin Aspart100 U
 
Inactive agentsDoseadditional_information
Arginine Hydrochloride  
Disodium Phosphate Dihydrate  
Glycerol  
Metacresol1.72 mg/ml 
Nicotinamide  
Phenol1.5 mg/mlconserv.
Zincum  
 
Source
Data was imported : 04.02.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home